Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 3/20 | 0.48 |
| ▸ | HRH1 | P35367 | 3/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | HTR2A | P28223 | 3/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9323529 | 0.87 | TRPA1 (0.34) | TRPA1 | |
| SCHEMBL8443421 | 0.85 | HRH1 (0.46) | HRH1HTR2ATDP1TAAR1 | |
| SCHEMBL6401479 | 0.80 | TRPA1 (0.45) | TRPA1LMNAHTR2ATAAR1KDM4E | |
| SCHEMBL19632871 | 0.80 | TRPA1 (0.45) | TRPA1LMNAHTR2ATAAR1KDM4E | |
| SCHEMBL1408602 | 0.80 | TRPA1 (0.45) | TRPA1LMNAHTR2ATAAR1KDM4E | |
| Ethylene Glycol SCHEMBL3192561 | 0.80 | CYP2D6 (0.44) | KDM4EALDH1A1CYP2D6SRC | |
| SCHEMBL25221462 | 0.77 | HTR2A (0.36) | HRH1LMNAHTR2ACYP2D6 | |
| SCHEMBL10352116 | 0.77 | SLC6A2 (0.37) | LMNAKDM4E | |
| SCHEMBL9860787 | 0.77 | HRH1 (0.39) | HRH1LMNAHTR2ATAAR1KDM4E | |
| SCHEMBL128570 | 0.77 | HRH1 (0.56) | TRPA1HRH1LMNAHTR2ATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114402096-A | Composition for tin-silver alloy electroplating comprising complexing agent | 巴斯夫欧洲公司 | 2022-04-26 | — | — | CN | disclosed |
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | SHOWA DENKO K.K. (JP) | 2010-02-04 | — | — | US | disclosed |
| EP-2030989-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING THIOL COMPOUND | Showa Denko K.K. (JP) | 2009-03-04 | — | — | EP | disclosed |
| US-5403502-A | Lubricating additive comprising a molybdenum (VI) hydroxymercaptide | PHILLIPS PETROLEUM COMPANY (US) | 1995-04-04 | — | — | US | disclosed |
| US-5169819-A | Impregnation of supported catalyst with aqueous ammonium sulfide solution which also contains sulfur-compound adjuvants then controlled heating | EUROPEENNE DE RETRAITEMENT DE CATALYSEURS (FR) | 1992-12-08 | — | — | US | disclosed |
| US-4729839-A | THIO ESTER-ETHERS, ESTERIFICATION, ETHERIFICATION | PHILLIPS PETROLEUM COMPANY (US) | 1988-03-08 | — | — | US | disclosed |
| EP-0249783-A1 | Water soluble lubricating additives | PHILLIPS PETROLEUM COMPANY (US) | 1987-12-23 | — | — | EP | disclosed |
| US-4636487-A | Process for the preparation of promoted catalysts | PHILLIPS PETROLEUM COMPANY (US) | 1987-01-13 | — | — | US | disclosed |
| US-4582594-A | MERCAPTO ALCOHOL AND MOLYBDENUM COMPOUND REACTION PRODUCT ACTIVATING HYDROREFINING CATALYST | PHILLIPS PETROLEUM COMPANY (US) | 1986-04-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029876-A1 | POLYMERIZATION ACCELERATOR, CURABLE COMPOSITION, CURED PRODUCT, AND PROCESS FOR PRODUCING THIOL COMPOUND | TMT1A, CCNT1, MGMT | TRPA1 966/4885HRH1 1842/4885LMNA 3457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.